CureLab Veterinary

Early Stage

ElenaVet®’s p62 plasmid technology is poised to revolutionize cancer treatment in dogs and cats by upregulating the body's immune system and lowering inflammation.

Overview

Raised to Date: Raised: $1,350

Total Commitments ($USD)

Platform

Netcapital

Start Date

12/22/2022

Close Date

02/22/2023

Min. Goal

$10,020

Max. Goal

$1,234,980

Min. Investment

$120

Security Type

Equity - Common

Series

Seed

Funding Type

RegCF

Price Per Share

$30.00

Pre-Money Valuation

$32,653,950

Rolling Commitments ($USD)

Status

Active

Reporting Date

02/03/2023

Days Remaining

19

% of Min. Goal

13%

% of Max. Goal

0%

Likelihood of Max
unlikely
Avg. Daily Raise

$31

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Dedham, Massachusetts

Industry

Pet Health, Food, and Services

Tech Sector

Medtech

Distribution Model

B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

CureLab Veterinary, with a valuation of $20 million, is raising funds on Netcapital. CureLab Veterinary product ElenaVet® is an anticancer/anti-inflammatory plasmid therapeutic that is poised to revolutionize cancer treatment in dogs and cats, extending the life of these family members. ElenaVet™ corrects the tumor microenvironment surrounding cancer cells, making it more favorable for anti-cancer immunity. Alex Shneider founded Curelab Veterinary in 2020. The current crowdfunding campaign has a minimum target of $ 10,020 and a maximum target of $1,234,980. The campaign proceeds will be used for compensation for managers, USDA consultant and regulatory, patent licensure and marketing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-450

$-1,136

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$252,544

$0

Long-Term Debt

$0

$0

Total Liabilities

$252,544

$0

Financials as of: 12/22/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
CureLab Veterinary on Netcapital 2022
$
Platform: Netcapital
Security Type: Equity - Common
Valuation: $32,653,950

Follow company

Follow CureLab Veterinary on Netcapital 2022
View on Netcapital